Rapid Influenza Diagnostic Tests Market, which had a value of US$ 800.8 million in 2020, is anticipated to grow at a CAGR of 8.7% from now through 2022. (2021-2031). According to Persistence Market Research’s forecasts, immunochromatographic assays have a sizable 66.8% market share.
Due to the sudden rise in viral infections and infectious diseases around the world in 2020, rapid influenza diagnostic testing made up about 3.4% of the market for infectious disease diagnostics overall.
Request for Free Sample Copy@ https://www.persistencemarketresearch.com/samples/31040
Rapid influenza diagnostic test demand analysis from 2016 to 2020 compared to market projections for 2021 to 2031
The rapid influenza diagnostic tests market was valued at US$ 800.8 Mn in 2020. Rapid diagnostic tests for influenza (RIDT) are used to identify and treat highly contagious diseases that spread through physical contact or the air. Accurate detection and diagnosis of influenza and other viral infections are just one advantage of RIDT.
One of the main factors driving the demand for rapid influenza diagnostic tests is the growing understanding of the importance of early viral disease detection among the global population. In an effort to reduce and eventually eliminate disease-related deaths, organisations are taking steps to encourage early detection.
Request For Customization@ https://www.persistencemarketresearch.com/request-customization/31040
Which Factors are Restraining Demand for Rapid Influenza Diagnostic Tests?
Main factors that influence the results of rapid influenza diagnostic kits are sensitivity and specificity. The antigenic heterogeneity of influenza viruses is the primary cause for the test’s complexity. As a result, the sensitivity and specificity of influenza diagnostic tests vary, which can affect the final test results.
False-negative results are more prevalent than false-positive results as a result, especially during peak influenza seasons, which is a primary factor restricting demand for rapid influenza diagnostic kits to some extent.
Stringent regulatory guidelines for approval of new kits may act as a market restraint. Global regulatory policies, cGMP, and inspection regimes tightening and supply chain security issues across emerging countries have a large impact on the availability and cost of final products, thereby negatively impacting rapid influenza diagnostic tests market growth.
Buy Now this Report@ https://www.persistencemarketresearch.com/checkout/31040
Key Segments Covered in Rapid Influenza Diagnostic Tests Industry Research
By Principle
- Immunochromatographic Assays
- Immunofluorescence Assays
- Nucleic Acid Amplification Test (NAAT)
By Test Type
- Influenza A Test
- Influenza B Test
- Influenza A+B Test
By Sample
- Throat Swab
- Nasal Swab
- Nasal Aspirate
- Nasal Wash
- Nasopharyngeal Swab
- Nasopharyngeal Aspirate
- Nasopharyngeal Wash
- Others
By End User
- Hospitals
- Diagnostic Centres
- Nursing Homes
- Office-based Settings
- Urgent Care Centres
- Retail Pharmacy Clinics
- Schools & Universities
- Public Health Camps
- Others
FAQ’S
- What is the sales forecast for rapid influenza diagnostic tests through 2031?
- What are the key trends shaping demand for rapid influenza diagnostic tests?
- What is the North American market outlook for rapid influenza diagnostic tests?
- How is the market in China projected to perform over the decade?
- How is demand for rapid influenza diagnostic tests expected to shape up in South Asia?
About Us
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact Us
Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]